Coraza, Emie B.
HRN: 11-71-03 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/23/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/23/2024
11/30/2024
IV
500mg
Q8
Tc Acute Appendicitis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes